Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromb...

Por Aapro, M, Osterwalder, B, Scherhag, A, Burger, H U
Publicado em 2009

Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanoma.

Por Kruit, W. H., Goey, S. H., Calabresi, F., Lindemann, A., Stahel, R. A., Poliwoda, H., Osterwalder, B., Stoter, G.
Publicado em 1995

Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.

Por Speck, B, Gratwohl, A, Nissen, C, Leibundgut, U, Ruggero, D, Osterwalder, B, Burri, H P, Cornu, P, Jeannet, M
Publicado em 1981

Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer.

Por Goey, S. H., Gratama, J. W., Primrose, J. N., Ward, U., Mertelsmann, R. H., Osterwalder, B., Verweij, J., Stoter, G.
Publicado em 1996

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

Por Pronk, L C, Vasey, P, Sparreboom, A, Reigner, B, Planting, A S Th, Gordon, R J, Osterwalder, B, Verweij, J, Twelves, C
Publicado em 2000

Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

Por Talbot, D C, Moiseyenko, V, Van Belle, S, O'Reilly, S M, Alba Conejo, E, Ackland, S, Eisenberg, P, Melnychuk, D, Pienkowski, T, Burger, H-U, Laws, S, Osterwalder, B
Publicado em 2002